Journals / Turkish Journal of Hematology / 2015 / Cilt: 32 - Sayı: 3

Thrombotic Microangiopathy with Complement Factor H Gene Mutations Unassociated with Atypical Hemolytic Uremic Syndrome

Atipik Hemolitik Üremik Sendrom ile İlişkili Olmayan Kompleman Faktör H Gen Mutasyonları Gösteren Trombotik Mikroanjiopati

Pages
275–280
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
🔖

Cite This Article

SERDAROĞLU, E., BERDELİ, A., AY, Y., S, G., D, K., TÖRET, E., KARAPINAR, T. H., ÖZCAN, E., MÜMİNOĞLU, N., KÖKER, S. A., JP, A., M, N., RJ, S., G, S., SR, R., CC, K., KL, S., SY, K., JR, G., VERGİN, C., OYMAK, Y. (2022). Thrombotic Microangiopathy with Complement Factor H Gene Mutations Unassociated with Atypical Hemolytic Uremic Syndrome. Turkish Journal of Hematology, Cilt: 32 - Sayı: 3, 275–280. https://ajindex.com/articles/606856

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (5)

  1. Patnaik MM, Parikh SA, Hanson CA, Tefferi A. Chronic myelomonocytic leukaemia: a concise clinical and pathophysiological review. Br J Haematol 2014;165:273-286.
  2. Xu Z, Shier L. Auer rods in a patient with chronic myelomonocytic leukemia type 2. Blood 2014;124:3828. Willis MS, McKenna RW, Peterson LC, Coad JE, Kroft SH. Low blast count myeloid disorders with Auer rods: a clinicopathologic analysis of 9 cases. Am J Clin Pathol 2005;124:191-198.
  3. Germing U, Strupp C, Kuendgen A, Aivado M, Giagounidis A, Hildebrandt B, Aul C, Haas R, Gattermann N. Refractory anaemia with excess of blasts (RAEB): analysis of reclassification according to the WHO proposals. Br J Haematol 2006;132:162-167.
  4. Orazi A, Bennett JM, Germing U, Brunning RD, Bain BJ, Thiele J. Chronic myelomonocytic leukemia. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW, (eds). WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. Lyon, France, IARC Press, 2008. Address for Correspondence: Smeeta GAJENDRA, M.D., Medanta-the Medicity, Department of Pathology and Laboratory Medicine, Haryana, India Phone: +90 09013590875 E-mail: [email protected] Ozsoylu S. High-dose intravenous methylprednisolone for thrombotic thrombocytopenic purpura. Acta Haematol 1990;84:110. Ozsoylu Ş, Bilgin K. Megadose methylprednisolone for the treatment of thrombocytopenic purpura. Turk J Med Sci 1994;22:129-130. Ozsoylu S. Corticosteroids in the treatment of thrombotic thrombocytopenic purpura. Acta Paediatr 2003;92:1229. George JN, Nester CM. Syndromes of thrombotic microangiopathy. N Engl J Med 2014;371:1847-1848.
  5. Gümrük F, Özsoylu Ş. Plazma infüzyonu ile düzeltilebilen trombositopeni. Yeni Tıp Dergisi 1992;9:57-58. Ozsoylu S. Mega-dose methylprednisolone in hematologic and non-hematologic disorders. Turk J Hematol 2010;27:130-131. Address for Correspondence: Şinasi ÖZSOYLU, M.D., Retired Professor of Pediatrics, Hematology and Hepatology, Honorary Fellow of American Academy of Pediatrics, Honorary Member of American Pediatric Society Phone: +90-256-2120020 E-mail: [email protected]